LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 52 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $396,113 | +1.8% | 400,000 | 0.0% | 0.06% | +3.8% |
| Q4 2022 | $389,250 | +0.6% | 400,000 | 0.0% | 0.05% | -8.6% |
| Q3 2022 | $387,000 | +1.0% | 400,000 | 0.0% | 0.06% | +3.6% |
| Q2 2022 | $383,000 | -43.7% | 400,000 | -42.9% | 0.06% | -33.3% |
| Q1 2022 | $680,000 | -2.4% | 700,000 | 0.0% | 0.08% | +3.7% |
| Q4 2021 | $697,000 | -0.6% | 700,000 | 0.0% | 0.08% | -10.0% |
| Q3 2021 | $701,000 | +1.3% | 700,000 | 0.0% | 0.09% | +3.4% |
| Q2 2021 | $692,000 | -4.6% | 700,000 | 0.0% | 0.09% | -6.5% |
| Q1 2021 | $725,000 | -14.4% | 700,000 | -22.2% | 0.09% | -11.4% |
| Q4 2020 | $847,000 | +4.3% | 900,000 | 0.0% | 0.10% | -13.9% |
| Q3 2020 | $812,000 | +2.9% | 900,000 | 0.0% | 0.12% | -10.9% |
| Q2 2020 | $789,000 | -4.5% | 900,000 | -10.0% | 0.14% | -12.2% |
| Q1 2020 | $826,000 | -4.3% | 1,000,000 | 0.0% | 0.16% | +28.9% |
| Q4 2019 | $863,000 | – | 1,000,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 64,118,000 | $55,709,000 | 4.91% |
| SYMPHONY ASSET MANAGEMENT LLC | 9,000,000 | $7,790,000 | 1.72% |
| CANYON CAPITAL ADVISORS LLC | 65,000,000 | $56,160,000 | 1.31% |
| CAMDEN ASSET MANAGEMENT L P /CA | 44,450,000 | $38,362,000 | 1.24% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 60,954,000 | $52,832,000 | 1.02% |
| Context Capital Management, LLC | 2,350,000 | $2,028,000 | 1.02% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,160,000 | $3,622,000 | 0.47% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $19,418,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 23,903,000 | $20,688,000 | 0.39% |
| WOLVERINE ASSET MANAGEMENT LLC | 36,633,000 | $31,784,000 | 0.37% |